ホーム › 非小細胞肺癌 › イリノイ州 › Waukegan
Waukegan、ILにおける非小細胞肺癌の臨床試験
Waukeganとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
被験者募集中第3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- City of Hope Chicago, Zion · 6マイル先
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8マイル先
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
被験者募集中第3相
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3マイル先
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- City of Hope® Cancer Center Chicago, Zion · 6マイル先
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Zion · 6マイル先
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
被験者募集中第3相
- Research Site, North Chicago · 3マイル先
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
被験者募集中第3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
被験者募集中第3相
- Cancer Treatment Centers of America (CTCA), Zion · 6マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
- 他1件
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
- 他1件
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
- 他1件
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
被験者募集中第2相
- City of Hope at Chicago, Zion · 6マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Waukeganにおける他の研究
- 肺がん16件の研究
- 乳がん12件の研究
- 潰瘍性大腸炎7件の研究
- 腎臓がん（腎細胞がん）7件の研究
- 卵巣がん6件の研究
- 転移性癌6件の研究
- 頭頸部扁平上皮癌6件の研究
- 大腸癌6件の研究
- 前立腺がん6件の研究
- 悪性黒色腫5件の研究
- 急性骨髄性白血病5件の研究
- クローン病5件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。